So now that they have a partner for distribution how does this affect MSB
1. Exposure to patients provides trial opportunities -> lower cost trials -> lower cash burn
2. Exposure to practitioners -> no need for salesforce -> lower cash burn
3. Extra $110m USD not tied to just Rex-L but free deploy funds for Rem-L confirmatory trials
4. Extra exposure to other ortho indications beyond backpain -> increased market opportunities
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group, page-190
-
- There are more pages in this discussion • 319 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.5¢ |
Change
-0.020(2.01%) |
Mkt cap ! $1.124B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 97.5¢ | $657.3K | 666.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 74853 | 97.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.0¢ | 46302 | 36 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 74853 | 0.975 |
15 | 201572 | 0.970 |
12 | 135230 | 0.965 |
12 | 134707 | 0.960 |
4 | 117484 | 0.955 |
Price($) | Vol. | No. |
---|---|---|
0.980 | 46302 | 36 |
0.985 | 25460 | 10 |
0.990 | 68822 | 32 |
0.995 | 77668 | 5 |
1.000 | 92548 | 8 |
Last trade - 11.47am 20/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |